• Registration and Reimbursement of New Cancer Medicines in Australia—Response to Letter to the Editor by Michael Wonder

    May 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome

    May 1, 2016, 00:00

  • Uma análise preliminar do desperdício de quimioterapia No tratamento do câncer

    Dec 1, 2015, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2015, 00:00

  • Analyses of Budget Impact Considering the Use of the Picture Archiving and Communication System

    Dec 1, 2015, 00:00

  • Evaluating the Long-Term Health Economic Implications of Improving the Proportion of Patients with Type 2 Diabetes Meeting Treatment Targets in Mexico

    Dec 1, 2015, 00:00

  • Epidemiology of Malaria in Latin America and the Caribbean from 1990 to 2009- Systematic Review and Meta-Analysis

    Dec 1, 2015, 00:00

  • Cost-effectiveness Analysis of Viscosupplementation versus Conventional Supportive Therapy for Knee Osteoarthritis in Colombia

    Dec 1, 2015, 00:00

  • Costing Dengue Fever Cases and Outbreaks- Recommendations from a Costing Dengue Working Group in the Americas

    Dec 1, 2015, 00:00

  • Comparación de costos y resultados sanitarios de usuarios con neumonia adquirida en comunidad atendidos en domicilio o en hospitalización tradicional- estudio exploratorio de 40 casos

    Dec 1, 2015, 00:00

  • Economic Costs Analysis of the Avoidable Mortality in Colombia 1998–2011

    Dec 1, 2015, 00:00

  • Equity in access to high cost drugs in Uruguay

    Dec 1, 2015, 00:00

  • Guide for Authors

    Dec 1, 2015, 00:00

  • Copyright/Subscription

    Dec 1, 2015, 00:00

  • Patient-Reported Outcomes in Latin America- Implementation in Research and Role in Emerging HTA Systems

    Dec 1, 2015, 00:00

  • Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Per ...

    Dec 1, 2015, 00:00

  • Results of the Inclusion of New Medications in the Obligatory Health System Plan in Colombia, 2012–2013

    Dec 1, 2015, 00:00

  • Análisis de costo efectividad de ondansetrón para el tratamiento del vómito en niños menores de cinco años con gastroenteritis en Colombia

    Dec 1, 2015, 00:00

  • Cost-Effectiveness of Canagliflozin versus Sitagliptin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus in Mexico

    Dec 1, 2015, 00:00

  • Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil- A Multicenter Study

    Dec 1, 2015, 00:00

  • Hospital Variation in Cesarean Delivery- A Multilevel Analysis

    Dec 1, 2015, 00:00

  • Impacto de una Política de Equivalencia Terapéutica en el Precio de Medicamentos en Chile

    Dec 1, 2015, 00:00

  • Table of Contents

    Dec 1, 2015, 00:00

  • Brief Latin American Update- One More ViHRI Annual Issue, and Another Exciting Biennial ISPOR Conference

    Dec 1, 2015, 00:00

  • Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia in Guatemala

    Dec 1, 2015, 00:00

  • Reviewer Acknowledgement

    Sep 1, 2015, 00:00

  • Editorial Board

    Sep 1, 2015, 00:00

  • The Potential Effects of Implementing the 2013 ACC/AHA Cholesterol Guidelines on the Use of Statins in a Large Health Maintenance Organization in Israel

    Sep 1, 2015, 00:00

  • Table of Contents

    Sep 1, 2015, 00:00

  • A Systematic Review of Community Pharmacists’ Interventions in Reducing Major Risk Factors for Cardiovascular Disease

    Sep 1, 2015, 00:00

  • Price Determinants of the Tendering Process for Pharmaceuticals in the Cyprus Market

    Sep 1, 2015, 00:00

  • Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary

    Sep 1, 2015, 00:00

  • Project Baiterek- A Patient Access Program to Improve Clinical Outcomes and Quality of Life in Children with Type 1 Diabetes in Kazakhstan

    Sep 1, 2015, 00:00

  • An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate Health State Values in the United Arab Emirates

    Sep 1, 2015, 00:00

  • High-Quality, Scientific Rigor, and Diversity- Value in Health Regional Issues Is Getting Its Impact

    Sep 1, 2015, 00:00

  • Copyright/Subscription

    Sep 1, 2015, 00:00

  • Costs of Hospital Stay in Specialized Diabetic Foot Department in Russia

    Sep 1, 2015, 00:00

  • Health-Related Quality-of-Life Measures- Evidence from Tunisian Population Using the SF-12 Health Survey

    Sep 1, 2015, 00:00

  • Cost-Minimization Analysis of Direct Cost of Sevelamer Carbonate and Lanthanum Carbonate in the Treatment of Patients with Chronic Kidney Disease Not on Dialysis in Bulgaria

    Sep 1, 2015, 00:00

  • The Hungarian Care Managing Organization Pilot Program

    Sep 1, 2015, 00:00

  • Guide for Authors

    Sep 1, 2015, 00:00

  • Analysis of the Financial Cost of Diabetes Mellitus in Four Cocoa Clinics of Ghana

    Sep 1, 2015, 00:00

  • Patterns of Care and Treatment Target Success among Persons with Type 2 Diabetes Mellitus in Dubai- A Retrospective Cohort Study

    Sep 1, 2015, 00:00

  • Economic Impact and Complications of Treated and Untreated Hepatitis C Virus Patients in Turkey

    Sep 1, 2015, 00:00

  • Does the Elderly’s Number of Prescribed Medications across Months Matter? National Cohort versus Single-Center Cohort

    May 1, 2015, 00:00

  • Incidence of Intravenous Medication Errors in a Chinese Hospital

    May 1, 2015, 00:00

  • Quality of life among Patients with Acute Coronary Syndrome in Malaysia

    May 1, 2015, 00:00

  • Guide for Authors

    May 1, 2015, 00:00

  • The State of Cost-Utility Analyses in Asia- A Systematic Review

    May 1, 2015, 00:00

  • Key Components of Increased Drug Expenditure in South Korea- Implications for the Future

    May 1, 2015, 00:00

  • Editorial Board

    May 1, 2015, 00:00

  • How Data Packages Lacking Phase III Pivotal Trial Data Can Support Regulatory Approval and Reimbursement for Oncologics in Australia

    May 1, 2015, 00:00

  • How Quality of Life as Patient-Reported Outcome Has Been Studied for Rheumatoid Arthritis in Chinese-Speaking Population

    May 1, 2015, 00:00

  • Economic Burden of Community-Acquired Pneumonia among Adults in the Philippines- Its Equity and Policy Implications in the Case Rate Payments of the Philippine Health Insurance Corporation

    May 1, 2015, 00:00

  • Supplier-Induced Demand for Chronic Disease Care in Japan- Multilevel Analysis of the Association between Physician Density and Physician-Patient Encounter Frequency

    May 1, 2015, 00:00

  • Inpatient Treatment Patterns and Health Care Expenditures for Hepatocellular Carcinoma among the Population with Urban Basic Health Insurance in China

    May 1, 2015, 00:00

  • Mapping and Analyzing Stakeholders in China’s Essential Drug System by Using a Circular Model- Who We Should Deal with Next?

    May 1, 2015, 00:00

  • Antiepileptic Drugs and Quality of Life in Patients with Epilepsy- A Tertiary Care Hospital-Based Study

    May 1, 2015, 00:00

  • Using Dynamic Transmission Modeling to Determine Vaccination Coverage Rate Based on 5-Year Economic Burden of Infectious Disease- An Example of Pneumococcal Vaccine

    May 1, 2015, 00:00

  • Table of Contents

    May 1, 2015, 00:00

  • Reviewer Acknowledgement

    May 1, 2015, 00:00

  • Health-Related Quality of Life and Willingness to Pay per Quality-Adjusted Life-Year Threshold—A Study in Patients with Epilepsy in China

    May 1, 2015, 00:00

  • Copyright/Subscription

    May 1, 2015, 00:00

  • Economic Burden of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

    May 1, 2015, 00:00

  • Comparing Patient and Physician Risk Tolerance for Bleeding Events Associated with Anticoagulants in Atrial Fibrillation—evidence from the United States and Japan

    May 1, 2015, 00:00

  • Efficacy and Safety of Thrombin-Receptor Antagonist (Atopaxar and Vorapaxar) in Patients with Acute Coronary Syndrome or Coronary Artery Disease—A Meta-Analysis of Randomized Controlled Trials

    May 1, 2015, 00:00

  • From Regulatory Approval to Subsidized Patient Access in the Asia-Pacific Region- A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan, and Thailand

    May 1, 2015, 00:00

  • Cost-Minimization Analysis of Metformin and Acarbose in Treatment of Type 2 Diabetes

    May 1, 2015, 00:00

  • Development and Psychometric Properties of a Tuberculosis-Specific Multidimensional Health-Related Quality-of-Life Measure for Patients with Pulmonary Tuberculosis

    May 1, 2015, 00:00

  • Reimbursement Coverage and Pricing Systems for Single-Use Devices in Asia-Pacific- Japan, Taiwan, Korea, and Australia Compared

    May 1, 2015, 00:00

  • Possessing Objectivity in Value in Health Regional Issues

    May 1, 2015, 00:00

  • Costo Utilidad de Colágena Polivinil-Pirrolidona en el Tratamiento de Osteartrosis de Rodilla en México

    Dec 1, 2014, 00:00

  • Table of Contents

    Dec 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Atorvastatin versus Rosuvastatin in Primary and Secondary Cardiovascular Prevention Populations in Brazil and Columbia

    Dec 1, 2014, 00:00

  • La Compleja Relación Entre Posición Socioeconómica, Estatus Migratorio y Resultados de Salud

    Dec 1, 2014, 00:00

  • Guide for Authors

    Dec 1, 2014, 00:00

  • Introducing the New Value in Health Regional Issues Journal- The Latin America Region Edition

    Dec 1, 2014, 00:00

  • The Update of the Mexican Health Care Formulary and Supply Catalog in the Context of the Health Technology Assessment

    Dec 1, 2014, 00:00

  • Copyright/Subscription

    Dec 1, 2014, 00:00

  • A Comparison of 1-Year Treatment Costs in Patients with Type 2 Diabetes Following Initiation of Insulin Glargine or Insulin Detemir in Argentina

    Dec 1, 2014, 00:00

  • Asthma Control and Cost in Latin America

    Dec 1, 2014, 00:00

  • Cost-Effectiveness of Biologic Agents in the Treatment of Moderate-to-Severe Psoriasis- A Brazilian Public Health Service Perspective

    Dec 1, 2014, 00:00

  • Guidance Document- Global Pharmacoeconomic Model Adaption Strategies

    Dec 1, 2014, 00:00

  • More Doctors- Thoughts about a Controversial Health Care Policy

    Dec 1, 2014, 00:00

  • Economic Evaluation of Four Drug Administration Systems in Intensive Care Units in Colombia

    Dec 1, 2014, 00:00

  • One Small Step for Latin America, One More Leap for Value in Health Regional Issues

    Dec 1, 2014, 00:00

  • Reviewer Acknowledgement

    Dec 1, 2014, 00:00

  • Editorial Board

    Dec 1, 2014, 00:00

  • Análisis Costo-Utilidad Del Uso De Adalimumab, Etanercept E Infliximab Para El Tratamiento De La Artritis Psoriásica En Uruguay

    Dec 1, 2014, 00:00

  • Assessment of Health Care and Economic Costs Due to Episodes of Acute Pesticide Intoxication in Workers of Rural Areas of the Coquimbo Region, Chile

    Dec 1, 2014, 00:00

  • The Cost of Melanoma and Kidney, Prostate, and Ovarian Cancers in Russia

    Sep 1, 2014, 00:00

  • Social Cost of Substance Abuse in Russia

    Sep 1, 2014, 00:00

  • Guide for Authors

    Sep 1, 2014, 00:00

  • Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements- A Markov Model

    Sep 1, 2014, 00:00

  • Table of Contents

    Sep 1, 2014, 00:00

  • Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection- A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition

    Sep 1, 2014, 00:00

  • Determinants of Cost-Related Nonadherence to Medications among Chronically Ill Patients in Maccabi Healthcare Services, Israel

    Sep 1, 2014, 00:00

  • Health Care Financing in Ethiopia- Implications on Access to Essential Medicines

    Sep 1, 2014, 00:00

  • An Overview of the Orphan Medicines Market in Turkey

    Sep 1, 2014, 00:00

  • Medical and Productivity Costs of Rheumatoid Arthritis in The Czech Republic- Cost-of-Illness Study Based on Disease Severity

    Sep 1, 2014, 00:00

  • Use of the EQ-5D Instrument and Value Scale in Comparing Health States of Patients in Four Health Care Programs among Health Care Providers

    Sep 1, 2014, 00:00

  • The Role of the National Health Insurance Fund Administration in the Development of Health Economics and Health Technology Assessment in Hungary

    Sep 1, 2014, 00:00

  • Mapping the Nottingham Health Profile onto the Preference-Based EuroQol-5D Instrument for Patients with Diabetes

    Sep 1, 2014, 00:00

  • Cost-effectiveness versus Cost-Utility Analyses- What Are the Motives Behind Using Each and How Do Their Results Differ?—A Polish Example

    Sep 1, 2014, 00:00

  • Health Facility Cost of Buruli Ulcer Wound Treatment in Ghana- A Case Study

    Sep 1, 2014, 00:00

  • Publisher’s Note

    Sep 1, 2014, 00:00

  • Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis

    Sep 1, 2014, 00:00

  • Editorial Board

    Sep 1, 2014, 00:00

  • Reviewer Acknowledgement

    Sep 1, 2014, 00:00

  • What Are the Challenges in Conducting Cost-of-Illness Studies?

    Sep 1, 2014, 00:00

  • Estimation of the Direct Cost of HIV-Infected Patients in Greece on an Annual Basis

    Sep 1, 2014, 00:00

  • Copyright/Subscription

    Sep 1, 2014, 00:00

  • Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece- Focusing on Price Reductions and Cost-Sharing Rates

    Sep 1, 2014, 00:00

  • Health Economic Data Requirements and Availability in the European Union- Results of a Survey Among 10 European Countries

    Sep 1, 2014, 00:00

  • Interim EQ-5D-5L Value Set for Poland- First Crosswalk Value Set in Central and Eastern Europe

    Sep 1, 2014, 00:00

  • Would It Matter to Expose Elderly Patients Who Took Digoxin to Chinese Medications?

    May 1, 2014, 00:00

  • Assessment of Preference for Hormonal Treatment–Related Health States among Patients with Breast Cancer

    May 1, 2014, 00:00

  • The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan—Implications for the Evaluation of Diabetes Mellitus Therapies

    May 1, 2014, 00:00

  • Cost-Effectiveness Analysis of CT Colonography for Colorectal Cancer Screening Program to Working Age in Japan

    May 1, 2014, 00:00

  • A Cost-Utility Analysis Comparing Standard Axillary Lymph Node Dissection with Sentinel Lymph Node Biopsy in Patients with Early Stage Breast Cancer in Thailand

    May 1, 2014, 00:00

  • Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants

    May 1, 2014, 00:00

  • A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China

    May 1, 2014, 00:00

  • Economic Impact of Pneumococcal Protein-D Conjugate Vaccine (PHiD-CV) on the Malaysian National Immunization Programme

    May 1, 2014, 00:00

  • Models to Predict the Burden of Cardiovascular Disease Risk in a Rural Mountainous Region of Vietnam

    May 1, 2014, 00:00

  • Guide for Authors

    May 1, 2014, 00:00

  • “Socialization of Health Care” in Vietnam- What Is It and What Are Its Pros and Cons?

    May 1, 2014, 00:00

  • Investigation of Evidence Sources for Health-Related Quality of Life in Cost-Utility Analysis of Pharmaceuticals in Japan

    May 1, 2014, 00:00

  • Economic Burden of Diabetes Mellitus on Patients with Respiratory Failure Requiring Mechanical Ventilation during Hospitalizations

    May 1, 2014, 00:00

  • Analysis of a Small Group of Stakeholders Regarding Advancing Health Technology Assessment in India

    May 1, 2014, 00:00

  • The Drug Reimbursement Decision-Making System in Iran

    May 1, 2014, 00:00

  • Estimating the Cost-Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Shanghai, China

    May 1, 2014, 00:00

  • Cost-Effectiveness of Periodontitis Management in Public Sector Specialist Periodontal Clinics- A Societal Perspective Research in Malaysia

    May 1, 2014, 00:00

  • The Patient-Related Burden of Pegylated-Interferon-α Therapy and Adverse Events among Patients with Viral Hepatitis C in Japan

    May 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Pneumococcal Vaccination with the Pneumococcal Polysaccharide NTHi Protein D Conjugate Vaccine in the Philippines

    May 1, 2014, 00:00

  • Table of Contents

    May 1, 2014, 00:00

  • Usefulness of Patient-Generated Index for HIV to Measure Individual Quality of Life- A Study from Thailand

    May 1, 2014, 00:00

  • Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b

    May 1, 2014, 00:00

  • Revisit What Is Next for Pharmacoeconomics and Outcomes Research in Asia

    May 1, 2014, 00:00

  • Cost-Effectiveness of Linezolid versus Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Confirmed Nosocomial Pneumonia in China

    May 1, 2014, 00:00

  • Comparative Analysis of Calendar Time-Specific and Conventional Propensity Score Analysis for Thiazolidinedione Use in Diabetes

    May 1, 2014, 00:00

  • Editorial Board

    May 1, 2014, 00:00

  • Epidermal Growth Factor Receptor Mutation Testing in Thailand- A Cost-Utility Analysis

    May 1, 2014, 00:00

  • Evaluation of the Psychometric Properties of the Malay Version of the Minnesota Nicotine Withdrawal Scale

    May 1, 2014, 00:00

  • Assessment of Effect of Diabetes on Health-Related Quality of Life in Patients with Coronary Artery Disease Using the EQ-5D Questionnaire

    May 1, 2014, 00:00

  • Cost-Utility Analysis of Home-Based Care for Treatment of Thai Hemophilia A and B

    May 1, 2014, 00:00

  • Estimating the Incidence and Prevalence of Chronic Hepatitis C Infection in Taiwan Using Back Projection

    May 1, 2014, 00:00

  • A Year of Significant Progress for Value in Health Regional Issues

    May 1, 2014, 00:00

  • Resource Utilization and Direct Medical Costs of Chronic Hepatitis C in Thailand- A Heavy but Manageable Economic Burden

    May 1, 2014, 00:00

  • Cost-Utility Analysis of Erythropoietin for Anemia Treatment in Thai End-Stage Renal Disease Patients with Hemodialysis

    May 1, 2014, 00:00

  • Treatment Costs of Stroke Related to Nonvalvular Atrial Fibrillation Patients in India—A Multicenter Observational Study

    May 1, 2014, 00:00

  • Reviewer Acknowledgement

    May 1, 2014, 00:00

  • Editorial Board

    Dec 1, 2013, 00:00

  • Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia

    Dec 1, 2013, 00:00

  • Atlas Argentino de Calidad de Vida Relacionada con la Salud- Análisis de los datos de la Encuesta Nacional de Factores de Riesgo por Provincias

    Dec 1, 2013, 00:00

  • Análisis de Minimización de Costo e Impacto Presupuestario del Tratamiento ARV con Abacavir/Lamivudina para el VIH/SIDA en México

    Dec 1, 2013, 00:00

  • Guide for Authors

    Dec 1, 2013, 00:00

  • Societal Preferences for EQ-5D Health States from a Brazilian Population Survey

    Dec 1, 2013, 00:00

  • Avaliação Econômica do Interferon Peguilado Alfa 2a em Combinação com a Ribavirina para o Tratamento da Infecção Pelo Genótipo 1 da Hepatite Crônica C- Comparação do Tratamento por 48 Semanas e Terapia Estendida

    Dec 1, 2013, 00:00

  • Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias- Versión en Español de la Lista de Comprobación CHEERS

    Dec 1, 2013, 00:00

  • Evaluation of the Stroke-Specific Quality-of-Life (SSQOL) Scale in Mexico- A Preliminary Approach

    Dec 1, 2013, 00:00

  • Análisis del Proceso de Actualización de Medicamentos en el Cuadro Básico y Catálogo de Insumos del Sector Salud

    Dec 1, 2013, 00:00

  • Dengue Epidemiology and Burden of Disease in Latin America and the Caribbean- A Systematic Review of the Literature and Meta-Analysis

    Dec 1, 2013, 00:00

  • Reviewer Acknowledgment

    Dec 1, 2013, 00:00

  • Lista de Comprobación CHEERS11Consolidated Health Economic Evaluation Reporting Standards. en Españ̆ol- Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias

    Dec 1, 2013, 00:00

  • The Impact of Psychotropic Drug Costs on the Brazilian Family Budget- An Analysis of the Family Budget Surveys of 2003 and 2009

    Dec 1, 2013, 00:00

  • Table of Contents

    Dec 1, 2013, 00:00

  • Copyright/Subscription

    Dec 1, 2013, 00:00

  • Carga de la Enfermedad Atribuible al Síndrome de Túnel del Carpo en la Población Trabajadora Colombiana- Una Aproximación a los Costos Indirectos de una Enfermedad

    Dec 1, 2013, 00:00

  • Costo-Efectividad de la Proteína C Reactiva, Procalcitonina y Escala de Rochester- Tres Estrategias Diagnosticas para la Identificación de Infección Bacteriana Severa en Lactantes Febriles sin Foco

    Dec 1, 2013, 00:00

  • Impact of the Pharma Economic Act on Diffusion of Innovation and Reduction of Costs in the Hungarian Prescription Drug Market (2007–2010)

    Sep 1, 2013, 00:00

  • The Methodological Challenges for the Estimation of Quality of Life in Children for Use in Economic Evaluation in Low-Income Countries

    Sep 1, 2013, 00:00

  • Table of Contents

    Sep 1, 2013, 00:00

  • Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

    Sep 1, 2013, 00:00

  • Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine

    Sep 1, 2013, 00:00

  • Performance Assessment of Ga District Mutual Health Insurance Scheme, Greater Accra Region, Ghana

    Sep 1, 2013, 00:00

  • Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa

    Sep 1, 2013, 00:00

  • Editorial Board

    Sep 1, 2013, 00:00

  • Transforming Public Servants’ Health Care Organization in Greece through the Implementation of an Electronic Referral Project

    Sep 1, 2013, 00:00

  • The Impact of Pharmaceutical Care Intervention on the Quality of Life of Nigerian Patients Receiving Treatment for Type 2 Diabetes

    Sep 1, 2013, 00:00

  • Guide for Authors

    Sep 1, 2013, 00:00

  • Children Hospitalized for Varicella- Complications and Cost Burden

    Sep 1, 2013, 00:00

  • What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers’ Preferences

    Sep 1, 2013, 00:00

  • Note from the Editors

    Sep 1, 2013, 00:00

  • Copyright/Subscription

    Sep 1, 2013, 00:00

  • Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries

    Sep 1, 2013, 00:00

  • The Process of Privatization of Health Care Provision in Poland

    Sep 1, 2013, 00:00

  • Patient-Reported Quality of Life During Antiretroviral Therapy in a Nigerian Hospital

    Sep 1, 2013, 00:00

  • Costs of Medically Attended Acute Gastrointestinal Infections- The Polish Prospective Healthcare Utilization Survey

    Sep 1, 2013, 00:00

  • An Audit of Diabetes-Dependent Quality of Life (ADDQOL) in Older Patients with Diabetes Mellitus Type 2 in Slovenia

    Sep 1, 2013, 00:00

  • Dossier System as a Practical Tool for Compiling Reimbursement Lists

    Sep 1, 2013, 00:00

  • Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt

    Sep 1, 2013, 00:00

  • Capacity Building for HTA Implementation in Middle-Income Countries- The Case of Hungary

    Sep 1, 2013, 00:00

  • Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes

    Sep 1, 2013, 00:00

  • Response to Letter from Dr. Jorge Revilla Beltri dated 22nd March, 2013

    Sep 1, 2013, 00:00

  • Systematic Review of Economic Evaluation Literature in Ghana- Is Health Technology Assessment the Future?

    Sep 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey- A Microsimulation Approach

    Sep 1, 2013, 00:00

  • ERRATUM

    Sep 1, 2013, 00:00

  • Economic Burden of Cardiovascular Diseases in the Russian Federation

    Sep 1, 2013, 00:00

  • Reviewer Acknowledgement

    Sep 1, 2013, 00:00

  • A Framework for Applying Health Technology Assessment in Cyprus- Thoughts, Success Stories, and Recommendations

    Sep 1, 2013, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »